Arginase levels and their association with Th17-related cytokines, soluble adhesion molecules (sICAM-1 and sVCAM-1) and hemolysis markers among steady-state sickle cell anemia patients

Annals of Hematology

Volumn 89, Issue 9, 2010, Pages 877-882

  Vilas Boas, Wendell ^a   Cerqueira, Bruno A V ^a   Zanette, Angela M D ^c   Reis, Mitermayer G ^a   Barral Netto, Manoel ^a   Goncalves, Marilda S ^a,b  

^a INSTITUTO OSWALDO CRUZ   (Brazil)

^b FEDERAL UNIVERSITY OF BAHIA   (Brazil)

^c Fundacao de Hematologia e Hemoterapia do Estado da Bahia HEMOBA   (Brazil)

Author keywords

Arginase; Arginine; Sickle cell anemia; Soluble adhesion molecules; TGF ; Th17 cells

Indexed keywords

ARGINASE; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 17; INTERLEUKIN 23; LACTATE DEHYDROGENASE; TRANSFORMING GROWTH FACTOR BETA; VASCULAR CELL ADHESION MOLECULE 1;

ADOLESCENT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME BLOOD LEVEL; ENZYME METABOLISM; FEMALE; HEMOLYSIS; HUMAN; MALE; PRIORITY JOURNAL; RETICULOCYTE; SICKLE CELL ANEMIA; TH17 CELL;

ADOLESCENT; ADULT; ANEMIA, SICKLE CELL; ARGINASE; BIOLOGICAL MARKERS; CHILD; CYTOKINES; FEMALE; HEMOLYSIS; HUMANS; INTERCELLULAR ADHESION MOLECULE-1; INTERLEUKIN-17; MALE; RETICULOCYTES; SOLUBILITY; T-LYMPHOCYTES, HELPER-INDUCER; VASCULAR CELL ADHESION MOLECULE-1; YOUNG ADULT;

EID: 77955619707     PISSN: 09395555     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00277-010-0954-9     Document Type: Article

References (26)

1. RP Hebbel R Osarogiagbon D Kaul 2004 The endothelial biology of sickle cell disease: inflammation and a chronic vasculopathy Microcirculation 11 129 151 10.1080/mic.11.2.129.151 1:CAS:528:DC%2BD2cXns1Glu7w%3D 15280088
2. I Okpala 2004 The intriguing contribution of white blood cells to sickle cell disease-a red cell disorder Blood Rev 18 65 73 10.1016/S0268-960X(03)00037- 7 10.1016/S0268-960X(03)00037-7 14684149 (Pubitemid 38200501)
3. Telen MJ (2007) Role of adhesion molecules and vascular endothelium in the pathogenesis of sickle cell disease. Hematology Am Soc of Hematol Educ Program 84-90
4. CR Morris GJ Kato M Poljakovic, et al. 2005 Dysregulated arginine metabolism, hemolysis-associated pulmonary hypertension and mortality in sickle cell disease JAMA 294 81 90 10.1001/jama.294.1.81 10.1001/jama.294.1.81 1:CAS:528:DC%2BD2MXlvVKmtrc%3D 15998894 (Pubitemid 41002842)
5. EW Iyamu R Cecil L Parkin G Woods K Ohene-Frempong T Asakura 2005 Modulation of erythrocyte arginase activity in sickle cell disease patients during hydroxyurea therapy Br J Haematol 131 389 394 10.1111/j.1365-2141.2005. 05772 10.1111/j.1365-2141.2005.05772.x 1:CAS:528:DC%2BD2MXht1yisbzN 16225659
6. Gladwin MT, Kato GJ (2005) Cardiopulmonary complications of sickle cell disease: role of nitric oxide and hemolytic anemia. Hematology Am Soc Hematol Educ Program 51-57 doi: 10.1182/asheducation-2005.1.51
7. KC Wood LL Hsu MT Gladwin 2008 Sickle cell disease vasculopathy: a state of nitric oxide resistance Free Radic Biol Med 44 1506 1528 10.1016j. freeradbiomed.2008.01.0085 10.1016/j.freeradbiomed.2008.01.008 1:CAS:528:DC%2BD1cXktlGls70%3D 18261470
8. SM Morris Jr 2002 Regulation of enzymes of the urea cycle and arginine metabolism Annu Rev Nutr 22 87 105 10.1146/annurev.nut.22.110801.140547 10.1146/annurev.nutr.22.110801.140547 1:CAS:528:DC%2BD38XmtF2ht7k%3D 12055339
9. IM Corraliza G Soler K Eichmann M Modolell 1995 Arginase induction by suppressors of nitric oxide synthesis (IL-4, IL-10 and PGE2) in murine bone marrow-derived macrophages Biochem Biophys Res Commun 206 667 673 10.1006/bbrc.1995.1094 1:CAS:528:DyaK2MXjtFejsbc%3D 7530004
10. P Schwarzenberger JK Kolls 2002 Interleukin 17: an example for gene therapy as a tool to study cytokine mediated regulation of hematopoiesis J Cell Biochem 38 Suppl 88 95 10.1002/jcb.10054 (Pubitemid 34477671)
11. B Stockinger M Veldhoen 2007 Differentiation and function of Th17 cells Curr Opin Immunol 19 281 286 10.10161j.coi.2007.04.005 10.1016/j.coi.2007.04.005 1:CAS:528:DC%2BD2sXlt1agsLg%3D 17433650 (Pubitemid 46687011)
12. S Taleb M Romain B Ramkhelawon C Uyttenhove G Pasterkamp O Herbin, et al. 2009 Loss of SOCS3 expression in T cells reveals a regulatory role for interleukin-17 in atherosclerosis J Exp Med 206 2067 2077 10.1084/jem.20090545 10.1084/jem.20090545 1:CAS:528:DC%2BD1MXht1SrtbvL 19737863
13. RE Eid DA Rao J Zhou SF Lo H Ranjbaran A Gallo, et al. 2009 Interleukin-17 and interferon-gamma are produced concomitantly by human coronary artery-infiltrating T cells and act synergistically on vascular smooth muscle cells Circulation 119 1424 1432 101161/circulationaha.108.827618 10.1161/CIRCULATIONAHA.108.827618 1:CAS:528:DC%2BD1MXivVentbw%3D 19255340
14. AL Pauleau R Rutschman R Lang A Pernis SS Watowich, et al. 2004 Enhancer-mediated control of macrophage-specific arginase I expression J Immunol 172 7565 7573 1:CAS:528:DC%2BD2cXks1ahu7c%3D 15187136
15. CD Mills K Kincaid JM Alt MJ Heilman AM Hill 2000 M-1/M-2 macrophages and the Th1/Th2 paradigm J Immunol 164 6166 6173 1:CAS:528:DC%2BD3cXktFWlsbw%3D 10843666
16. CR Morris FA Kuypers S Larkin E Vichinsky L Styles 2000 Patterns of arginine and nitric oxide in sickle cell disease patients with vaso-occlusive crisis and acute chest syndrome J Pediatr Hematol Oncol 22 515 520 10.1097/00043426-200011000-00009 1:STN:280:DC%2BD3M%2FnvFGrtA%3D%3D 11132219
17. CR Morris SM Morris Jr W Hagar J Van Warmerdam S Claster D Kepka-Lenhart L Machado FA Kuypers EP Vichinsky 2003 Arginine therapy: a new treatment for pulmonary hypertension in sickle cell disease? Am J Respir Crit Care Med 168 63 69 10.1164/rccm.200208-967OC 10.1164/rccm.200208-967OC 12626350 (Pubitemid 37046634)
18. CR Morris FA Kuypers S Larkin, et al. 2000 Arginine therapy: a novel strategy to induce nitric oxide production in sickle cell disease Br J Haematol 111 498 500 10.1111/j.1365-2141.2000.12403 10.1046/j.1365-2141.2000.02403.x 1:CAS:528:DC%2BD3MXhtlyqsg%3D%3D 11122090
19. RP Rother L Bell P Hillmen MT Gladwin 2005 The clinical sequelae of intravascular hemolysis and extracellular plasma hemoglobin: a novel mechanism of human disease JAMA 293 1653 1662 10.1001/jama.293.13.1653 1:CAS:528:DC%2BD2MXjtV2qtL8%3D 15811985 (Pubitemid 40471796)
20. E Vichinsky 2002 New therapies in sickle cell disease Lancet 360 629 631 10.1016/S0140-6736(02)09776-3 12241949 (Pubitemid 35238025)
21. SK Lee JH Kim WS Yang SB Kim SK Park JS Park 2002 Exogenous nitric oxide inhibits VCAM-1 expression in human peritoneal mesothelial cells. Role of cyclic GMP and NF-kappaB Nephron 90 447 454 10.1159/000054733 10.1159/000054733 1:CAS:528:DC%2BD38XivVOru74%3D 11961404 (Pubitemid 34310109)
22. YN Nabah T Mateo M Cerda-Nicolas A Alvarez M Martinez AC Issekutz MJ Sanz 2005 L-NAME induces direct arteriolar leukocyte adhesion, which is mainly mediated by angiotensin-II Microcirc 12 443 453 10.1080/10739680590960962 10.1080/10739680590960962 1:CAS:528:DC%2BD2MXmt1Gkurk%3D (Pubitemid 41122468)
23. J MacMicking QW Xie C Nathan 1997 Nitric oxide and macrophage function Annu Rev Immunol 15 323 350 10.1146/annurev.immunol.15.1.323 10.1146/annurev.immunol.15.1.323 1:CAS:528:DyaK2sXisVCmsLo%3D 9143691 (Pubitemid 27169284)
24. M Modolell IM Corraliza F Link G Soler K Eichmann 1995 Reciprocal regulation of nitric oxide synthase/arginase balance in mouse bone marrow-derived macrophages by Th1 and Th2 cytokines Eur J Immunol 25 1101 1104 10.1002/eji.1830250436 1:CAS:528:DyaK2MXltFOmtL4%3D 7537672
25. M Munder K Eichmann M Modolell 1998 Alternative metabolic states in murine macrophages reflected by the nitric oxide synthase/arginase balance: competitive regulation by CD4+ T cells correlates with Th1/Th2 phenotype J Immunol 160 5347 5354 1:CAS:528:DyaK1cXjt1Gnu7s%3D 9605134
26. FN Ziyadeh 2004 Mediators of diabetic renal disease: the case for TGF-Beta as the major mediator J Am Soc Nephrol 15 Suppl 1 S55 S57 10.1097/01.asn.0000093460.24823.5B 10.1097/01.ASN.0000093460.24823.5B 1:CAS:528:DC%2BD3sXps1Sitbs%3D 14684674